Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/119516
Título: Statins: Are Lipid-lowering Drugs Useful in Sarcomas?
Autores/as: Garcia Castellano, Jose Manuel 
Martínez Aragón, Nerea
García Padrón, David
Guerra Hernández, Carlos Borja 
Ramírez Sánchez, Margarita
Vera Gutiérrez, Vicente
Garcés Martín, Gerardo 
Fernández Pérez, Leandro Fco 
Clasificación UNESCO: 32 Ciencias médicas
Palabras clave: Sarcoma
Cholesterol metabolism
Mevalonate
HMGCoAR
Statin, et al.
Fecha de publicación: 2022
Editor/a: INTECH OPEN
Resumen: Sarcomas are rare tumors that are difficult to treat. Many of them are chemo-resistant and with a high tendency to recur. Hence, finding new treatments is imperative in these tumors. Metabolic changes in tumor biology have become an essential characteristic in carcinogenesis processes, highlighting among them the role of lipids in these events, mainly cholesterol biosynthesis. Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoAR), a key enzyme in the mevalonate pathway responsible for cholesterol synthesis, have an effect beyond the reduction in plasma cholesterol levels. These are the so-called pleiotropic effects of statins, responsible for some of the antitumor action of statins. Although there are considerable epidemiological and preclinical evidences that support the use of these medicaments in the treatment of sarcomas as adjuvant reprofiled drugs, clinical trials are disparate and heterogeneous, and do not provide enough information to help determine the convenience of their use, being necessary more studies to evaluate the efficacy and safety of statins in sarcomas. The purpose of this review is to update the role played by the reprofiled statins in the treatment of sarcomas.
URI: http://hdl.handle.net/10553/119516
DOI: 10.5772/intechopen.107127
Fuente: Bone Tumors - Recent Updates
Colección:Capítulo de libro
Adobe PDF (1,99 MB)
Vista completa

Visitas

134
actualizado el 05-oct-2024

Descargas

63
actualizado el 05-oct-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.